ISSN 2287-0237 (online)/ 2287-9674 (print)
Special Feature
Vilaichone R, MD Helicobacter Pylori Infection in Bhutan H elicobacter pylori (H. pylori) is a gram-negative bacterium that colonizes the human stomach, and is recognized to play an important role in the pathogenesis of various upper gastrointestinal diseases including gastritis, peptic ulcer, gastric cancer, and mucosa-associated lymphoid tissue (MALT) lymphoma. [1] [2] [3] Infection with H. pylori almost always results in chronic gastritis, but only a small population of infected patients have developed into more severe diseases such as peptic ulcer and gastric cancer. Interaction between host, bacteria and environment factors might be key processes for developing disease outcomes. In Asia, gastric cancer is still a main health problem and the prevalence of gastric cancer geographically varies greatly between each location. 2, 3 Bhutan is a small landlocked country in South Asia, located at the eastern end of the Himalayas and shares borders with the South, East and West with the Republic of India and to the North with the People's Republic of China. Bhutan has a population of 700,000 with an area of 38,816 Sq.m. The terrain consists mostly of steep and high mountains with elevation ranging from 660-23,000 ft. The ASR of gastric cancer in Bhutan was reported to be 24.2/100,000 being relatively high among Asian countries. 4, 5 Although several studies focused on the prevalence of H. pylori infection conducted in many countries with different socioeconomic, cultural, and racial groups, 6, 7 the prevalence of H. pylori infection in Bhutan has not been investigated. We disclosed the infection rate of H. pylori in Bhutan and these fi ndings can be used as baseline epidemiological data for further research to understand the epidemiology of H. pylori infection in Bhutan and Asian countries.
Prevalence of H. pylori infection in Bhutan
We went to Bhutan 3 times for the Thailand-Japan-Bhutan 
Explanation of high H. pylori infection in Bhutan
We demonstrated that the prevalence of H. pylori in Bhutan was 66.2%. In contrast with developed countries, H. pylori infections occur earlier in life and with a higher frequency in the developing world. 4, 5 While the prevalence of the infection has dropped signifi cantly in many parts of North America, Western Europe and some countries in Asia, no such decline has been noted in the developing world. 4 The possible explanation might be from poor economic status and sanitation in many develop- 
Conclusion
High incidence of gastric cancer in Bhutan may contribute to a high prevalence of H. pylori infection. Therefore, any eradication therapy of H. pylori could lead to a drop in H. pylori-related upper GI diseases such as chronic gastritis, peptic ulcer diseases and gastric cancer. However, we should remain cautious when considering any H. pylori eradication therapy in Bhutan. Even when eradication therapy for H. pylori is successful, infection frequently reoccurs in patients in developing countries where there is a high prevalence of H. pylori infection. 4 Recurrent infection is either a repeat of the original infection or reinfection with a new strain. The most important move should be an attempt to improve sanitary conditions across the country to decrease the prevalence of H. pylori in Bhutan. (5B) (5A) Vilaichone R, et al.
